SMS Pharmaceuticals has acquired 4.9% stake by investing Rs 9,80,000 in Provenio Astral International LLP (Formerly Known as Studiom Square LLP).
This strategic partnership may help the company to expand its business in overseas and also If the company wish to establish any facility in overseas in future. This partnership will benefit to procure established connectivity facility with lesser price than the market.
SMS Pharmaceuticals is a global player in API and intermediates manufacturing having a strong research and manufacturing team supported by state?of?the?art facilities.
